The Discounted Cash Flow (DCF) valuation of Consun Pharmaceutical Group Ltd (1681.HK) is 20.75 HKD. With the latest stock price at 11.50 HKD, the upside of Consun Pharmaceutical Group Ltd based on DCF is 80.5%.
Based on the latest price of 11.50 HKD and our DCF valuation, Consun Pharmaceutical Group Ltd (1681.HK) is a buy. buying 1681.HK stocks now will result in a potential gain of 80.5%.
Range | Selected | |
WACC / Discount Rate | 8.7% - 11.4% | 10.0% |
Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
Fair Price | 18.15 - 24.58 | 20.75 |
Upside | 57.8% - 113.8% | 80.5% |